News und Analysen

Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results

Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results

Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results

Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results

Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results

Even though it's only Tuesday, BioXcel Therapeutics (NASDAQ: BTAI) is having a week to forget. After the biotech's share price tanked on Monday on the back of less-than-inspiring quarterly results

Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their

Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their

Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their

Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their

Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their

Rivian (NASDAQ: RIVN) stock is getting some attention from Wall Street today, and the market is taking note. Investors are driving shares of the electric pickup truck manufacturer into their

Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with

Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with

Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with

Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with

Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with

Charged up about the electric truck maker's prospects, investors chose to park shares of Rivian (NASDAQ: RIVN) in their portfolios yesterday upon learning of management's interest in partnering with

Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology

Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology

Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology

Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology

Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology

Shares of Arcutis Biotherapeutics (NASDAQ: ARQT) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology